What will become of biotech in 2019? What’s the legacy of Sarepta Therapeutics? And how do you say “overhyped” in Mandarin?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Ike Swetlitz joins us to discuss the IBM’s latest travails with Watson Health, the purportedly revolutionary technology that has quickly become a cautionary tale. Then, we look forward to 2019 and the major biotech stories we’ll be keeping an eye on throughout the year. Finally, Dr. Ed Kaye, CEO of Stoke Therapeutics, joins us to talk about his new company, relive his days at Sarepta, and, bravely, answer rapid-fire questions in a lightning round.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email email@example.com.
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at firstname.lastname@example.org.